ReviewDigestive diseases and sciences2022
Imaging of Bowel Lymphoma: A Pictorial Review.
Review in Digestive diseases and sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 3 citations in OpenAlex.
- Diagnostic challenges and clinical management of inflammatory myofibroblastic tumor: a retrospective case series study.Translational cancer research · 2025Article
- Small Intestine Tumors: Diagnostic Role of Multiparametric Ultrasound.Healthcare (Basel, Switzerland) · 2025Review
- Computed tomography-based radiomics combined with machine learning allows differentiation between primary intestinal lymphoma and Crohn's disease.World journal of gastroenterology · 2024Article
- Nomogram based on computed tomography images and clinical data for distinguishing between primary intestinal lymphoma and Crohn's disease: a retrospective multicenter study.Frontiers in medicine · 2023Article
- Gut and liver involvement in pediatric hematolymphoid malignancies.World journal of gastrointestinal oncology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intestinal lymphoma, although rare, is the second most common extra-nodal site of lymphoma, following stomach. It is usually secondary to systemic involvement and is predominantly of non-Hodgkin's subtype. In addition to the risk factors for lymphomas occurring elsewhere, certain risk factors are specific for intestinal lymphoma. These include enteropathies such as celiac disease and inflammatory bowel disease. Imaging is the cornerstone in the management of intestinal lymphoma. Contrast-enhanced computed tomography or positron emission tomography-computed tomography are the preferred modalities for diagnosis, staging, monitoring response to treatment, and for follow-up evaluation. Bowel lymphomas can have various morphological patterns on imaging; however, certain characteristic features, if present, may prove invaluable in its diagnosis. Hence, it is imperative to be acquainted with the myriad of imaging findings in bowel lymphoma and its complications which may not only help in vivo distinction from other commoner bowel lesions but alter the management accordingly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.